Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicki A Morrison

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Journal of Geriatric Oncology|January 11, 2021
A medicare database analysis of practice patterns in patients with mantle cell lymphomaJessalyn A Weaver, Yi Peng, Yuanyuan Ji, et al.
Journal of Geriatric Oncology|January 14, 2025
Association of age and performance status with adverse events in older adults with diffuse large B-cell lymphoma receiving frontline R-CHOP therapy: Alliance 151930, a secondary analysis of the phase III trial CALGB 50303Vicki A Morrison, Jennifer Le-Rademacher, Olivia Bobek, et al.
Leukemia & Lymphoma|February 13, 2004
Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapyGary H Lyman, Vicki A Morrison, David C Dale, et al.
Leukemia & Lymphoma|September 15, 2017
The impact of Agent Orange exposure on prognosis and management in patients with chronic lymphocytic leukemia: a National Veteran Affairs Tumor Registry StudyCraig Mescher, David Gilbertson, Nicole M Randall, et al.
Journal of Geriatric Oncology|February 26, 2022
Geriatric assessment in older adults with non-Hodgkin lymphoma: A Young International Society of Geriatric Oncology (YSIOG) review paperOthman Salim Akhtar, Li-Wen Huang, Mazie Tsang, et al.
Journal of Geriatric Oncology|October 24, 2017
The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapiesParameswaran Hari, Dorothy Romanus, Katarina Luptakova, et al.
Journal of Geriatric Oncology|February 3, 2019
Mortality by a proxy performance status as defined by a claims-based measure for disability status in older patients with newly diagnosed multiple myeloma in the United StatesShuling Li, Tanya Natwick, Jiannong Liu, et al.
Future Oncology (London, England)|February 14, 2019
Evaluation of treatment patterns and survival among patients with diffuse large B-cell lymphoma in the USAVicki A Morrison, Yaping Shou, Jill A Bell, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 30, 2019
Treatment Patterns and Survival Outcomes in Patients With Follicular Lymphoma: A 2007 to 2015 Humedica Database StudyVicki A Morrison, Yaping Shou, Jill A Bell, et al.
Leukemia & Lymphoma|December 15, 2016
Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494)Vicki A Morrison, Edie A Weller, Thomas M Habermann, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Journal of Geriatric Oncology|January 11, 2021
A medicare database analysis of practice patterns in patients with mantle cell lymphomaJessalyn A Weaver, Yi Peng, Yuanyuan Ji, et al.
Journal of Geriatric Oncology|January 14, 2025
Association of age and performance status with adverse events in older adults with diffuse large B-cell lymphoma receiving frontline R-CHOP therapy: Alliance 151930, a secondary analysis of the phase III trial CALGB 50303Vicki A Morrison, Jennifer Le-Rademacher, Olivia Bobek, et al.
Leukemia & Lymphoma|February 13, 2004
Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapyGary H Lyman, Vicki A Morrison, David C Dale, et al.
Leukemia & Lymphoma|September 15, 2017
The impact of Agent Orange exposure on prognosis and management in patients with chronic lymphocytic leukemia: a National Veteran Affairs Tumor Registry StudyCraig Mescher, David Gilbertson, Nicole M Randall, et al.
Journal of Geriatric Oncology|February 26, 2022
Geriatric assessment in older adults with non-Hodgkin lymphoma: A Young International Society of Geriatric Oncology (YSIOG) review paperOthman Salim Akhtar, Li-Wen Huang, Mazie Tsang, et al.
Journal of Geriatric Oncology|October 24, 2017
The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapiesParameswaran Hari, Dorothy Romanus, Katarina Luptakova, et al.
Journal of Geriatric Oncology|February 3, 2019
Mortality by a proxy performance status as defined by a claims-based measure for disability status in older patients with newly diagnosed multiple myeloma in the United StatesShuling Li, Tanya Natwick, Jiannong Liu, et al.
Future Oncology (London, England)|February 14, 2019
Evaluation of treatment patterns and survival among patients with diffuse large B-cell lymphoma in the USAVicki A Morrison, Yaping Shou, Jill A Bell, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 30, 2019
Treatment Patterns and Survival Outcomes in Patients With Follicular Lymphoma: A 2007 to 2015 Humedica Database StudyVicki A Morrison, Yaping Shou, Jill A Bell, et al.
Leukemia & Lymphoma|December 15, 2016
Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494)Vicki A Morrison, Edie A Weller, Thomas M Habermann, et al.
Pageof 9